loader image

Global Regenerative Trade

News

Global OrthoBiologic, Inc. announces Manufacturing Agreement with Quality Precision Technology!

Quality Precision Technology (QPT) has signed a contract manufacturing agreement with Global OrthoBiologic, Inc. (GOB). GOB and other medical device companies represent customers that are an essential part of the medical community vision, which is to manufacture cutting edge medical devices and technologies that will be successful by being used in innovative yet common, high …

Global OrthoBiologic, Inc. announces Manufacturing Agreement with Quality Precision Technology! Read More »

Global OrthoBiologic, Inc. (GOB) announces a strategic Joint Venture with Lamar Holidays

Dubai, UAE (October 31, 2016). Global OrthoBiologic, Inc. (GOB), a leader in regenerative medicine currently doing business in more than 30 countries, announces a strategic Joint Venture with Lamar Holidays, a worldwide luxury travel and tourism company to provide Medical Tourism. Medical tourism is defined as traveling from one location to another with a purpose …

Global OrthoBiologic, Inc. (GOB) announces a strategic Joint Venture with Lamar Holidays Read More »

GOB joint venture with MBSI

Lutry, Switzerland (October 10, 2016) Global OrthoBiologic Inc. (GOB), a leader in regenerative medicine currently doing business in 30 countries, announces a strategic Joint Venture with MBSI Medical Biobank Swiss Institute Group, a leader in stem cells and regenerative medicine.  This partnership will create a strong alliance between GOB and its global distribution network and …

GOB joint venture with MBSI Read More »

GOB ON A SECOND VISIT TO DUBAI AFTER THE HUGE SUCCESS AT ARAB HEALTH, 2016

After the successful presentation at Arab Health in January, the Global OrthoBiologic, Inc. team was invited again to Dubai to discuss new business ventures and opportunities.  Randy Beimel, President of GOB and Mihail Blagoev, VP International Business Development were warmly welcomed during their one-week visit. February 27: The GOB team was invited by Dr. Hesham …

GOB ON A SECOND VISIT TO DUBAI AFTER THE HUGE SUCCESS AT ARAB HEALTH, 2016 Read More »

TriAlpha CO orders 300 BMAC kits after a successful GOB training in Kuwait

The Global OrthoBiologic Inc. (GOB) team just returned home after one week training in Kuwait.  Our team was represented by company President Mr. Randy Beimel, VP International Business Development Mr. Mihail Blagoev, scientific officer Dr. Dzihan Abazovic and Dr. Fabio Valerio Sciarretta. The team visited different hospitals every day, giving presentations and lecturing in front …

TriAlpha CO orders 300 BMAC kits after a successful GOB training in Kuwait Read More »

GOB TEAM ON A MEDICAL TRAINING TRIP IN THE BALKANS

The Global OrthoBiologic Team successfully returned from their first medical training in the Balkans. Serbia was the first stop on the trip. The GOB team was represented by Dr. Himanshu Bansal, scientific advisory member, Mr. Randy Beimel, GOB President and Mr. Mihail Blagoev, VP International Business Development. Another scientific advisory member of our board – …

GOB TEAM ON A MEDICAL TRAINING TRIP IN THE BALKANS Read More »

GOB with a succesful product presentation on Arab Health 2016

The Arab Health Exhibition & Congress is the largest healthcare exhibition & medical congress in the Middle East. The 2016 exhibition showcased more than 4,000 companies exhibiting their latest innovations to more than 130,000 healthcare professionals attending from 163 countries. We are happy to announce that we successfully presented all the companies and products from our portfolio …

GOB with a succesful product presentation on Arab Health 2016 Read More »

GOB and Global Biomedikal announcing the official launch

Global OrthoBiologic Inc.(GOB) together with its Turkish partner Global Biomedikal is pleased to announce the official launch of the Magellan BMAC kit in two of the largest cities in Turkey – Ankara and Istanbul.  Medical trainings and meetings were organized in front of key doctors and university professors. The first procedure was performed in Hacettepe …

GOB and Global Biomedikal announcing the official launch Read More »

Vivostat Logo

THE VIVOSTAT® SYSTEM

The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.

THE FULLY AUTOMATED VIVOSTAT® SYSTEM CONSISTS OF THREE COMPONENTS: